Tuberculosis: MSF welcomes WHO revision in TB guidelines and urges greater access and affordability in India to new regimen
August 4, 2020New Delhi, India: Doctors Without Borders/Medecins Sans Frontieres (MSF) has welcomed the revision made by the World Health Organisation (WHO) to its tuberculosis (TB) guidelines, allowing for safe use of a treatment regimen including both bedaquiline and delamanid for drug-resistant...
Read more
Access to medicines: Governments must scale up better TB treatment as J&J drops crucial drug price
July 6, 2020NEW YORK/GENEVA - The pharmaceutical corporation Johnson & Johnson (J&J) has announced a reduced price of US$1.50 [1] per day for the tuberculosis (TB) drug bedaquiline, which is an important step that should allow more people with drug-resistant forms of TB...
Read more
Mumbai: As the COVID-19 pandemic rages on, “I hope my treatment can continue and I can be cured.”
April 10, 2020“We spent hundreds of rupees in private health clinics to trying to cure my tuberculosis, but none of the medication worked. The treatment included daily painful injections with lots of side-effects like vomiting, fatigue, loss of appetite… and sometimes even...
Read more
World Tuberculosis Day: “It’s time” to end the suffering and accelerate access to all oral regimen
March 24, 2020Mumbai (India) - As of February 2020, the MSF private clinic in Govandi, Mumbai has initiated 188 drug-resistant tuberculosis (DR-TB) patients on treatment regimen which includes Bedaquiline and Delamanid. Globally, an estimated 10 million people fell ill with tuberculosis (TB) in 2018...
Read more
COVID-19: Avoiding a ‘second tragedy’ for those with TB
March 23, 2020As the world grapples with the coronavirus COVID-19 global pandemic, Doctors Without Borders/Médecins Sans Frontières (MSF) is concerned for vulnerable groups worldwide. People with tuberculosis (TB) are among the groups that may be particularly affected. Special attention will be needed to safeguard the continuity...
Read more
Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug
January 23, 2020As J&J release earnings, MSF protests price of lifesaving TB drug in front of New York Stock Exchange New York, 22 January 2020—Médecins Sans Frontières (MSF) protested in front of the New York Stock Exchange in New York today, demanding...
Read more
MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people
October 30, 2019Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. Hyderabad, 30 October – Doctors Without Borders/Médecins Sans Frontières (MSF) joined tuberculosis (TB) activists to disrupt...
Read more
Chhattisgarh: Treating tuberculosis in the jungle
October 29, 2019Since 2006, MSF is working in Sukma district of Southern Chhattisgarh in India, place of a longstanding low-intensity conflict between Indian security forces and Left-Wing Extremist group. The MSF team works to provide primary health care services to the population...
Read more
Access to medicines: MSF demands Johnson & Johnson reduce price of lifesaving TB drug
October 10, 2019GENEVA - Doctors Without Borders/Médecins Sans Frontières (MSF) has launched a global campaign calling on pharmaceutical corporation Johnson & Johnson (J&J) to lower the price of its anti-tuberculosis medicine bedaquiline to no more than US$1 per day for people everywhere who...
Read more
Tuberculosis: Promising new tuberculosis drug pretomanid approved, but will it be affordable?
August 15, 2019GENEVA/NEW YORK – Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the approval by the US Food and Drug Administration (FDA) of a combination regimen containing a new drug, pretomanid, for the treatment of extensively drug-resistant tuberculosis (XDR-TB). As the third...
Read more
Manipur: Providing patient-centered HIV, TB, and hepatitis care to patients
July 30, 2019When Thongsei Lupho, 44, first started feeling unwell, he suspected he had contracted Tuberculosis. He visited MSF’s clinic in Moreh, on the Indo-Myanmar border, where he was diagnosed with HIV. Lupho had used drugs in the past to gain social...
Read more
World Tuberculosis Day: Treating the untreatable
March 24, 2019With 84,000 cases of drug-resistant tuberculosis, India has the highest burden of DR-TB in the world. In Mumbai, MSF has been providing not just medical treatment but holistic care to people living with DR-TB. Watch this video to find out...
Read more
